Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials^*

Click to increase image sizeClick to decrease image size

Acknowledgements

The authors thank M. Szymaniak-Vits, P. Otte, Dr. J. Waldschmidt, Prof. Dr. M. Hug, Dr. M. Ruch, PD Dr. M. Boeker, M. Naegele and S. Müller, all UKF for their significant support, fruitful discussion, and valuable suggestions. We are highly obliged to the DSMM, GMMG, EMN, and IMWG experts for their insightful comments that have inspired us to further improve the manuscript, to Daniel Textor for diligent data management using our MM database, and to Dr. Patrique Wolfrum for IT support.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2018.1448084.

Additional information

Funding

This work was supported by an independent educational grant from Celgene and Amgen and German Cancer Aid [DKH #111424], data analysis, interpretation, and writing of the paper were independently performed by all authors and remain UKF intellectual property [Educational Grants to ME + RW].